Dan Leonard

Q: What is Dan Leonard's success rate?

Dan Leonard currently has a success rate of 98.77474601615636.

Q: What is the average return of Dan Leonard's calls?

Their stock ratings have generated an average return of 21.50661879731465.

RBC Capital | Healthcare

Dan Leonard is an analyst from RBC Capital specializing in the Healthcare sector. Ranked #715 out of 4718 analysts, they have issued 39 stock ratings with a success rate of 98.77% and an average return of 21.51%.

Dan Leonard has a well-established track record, with 39 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 98.77% and an average return of 21.51%, underscoring their expertise and ability to identify winning opportunities for investors.

#715

Out of 4718

Total Ratings

+98.77%

Success Rate

+21.51%

Average Return

Recent Ratings Analysis

TECH

Hold

Jul 09, 2026

Target

$73.00

Current

$71.30

Performance

0.21%

Dan Leonard rated TECH as Sector Perform on Jul 09, 2026, setting a price target of 73. The Hold stance appears justified, as shares hovered around 71.3 with a 0.21% move.

WAT

Buy

Jul 09, 2026

Target

$435.00

Current

$376.43

Performance

-0.19%

On Jul 09, 2026, WAT was given a Outperform rating by Dan Leonard, with a target price of 435. The stock traded sideways with a -0.19% move, keeping the bullish thesis unresolved.

NTRA

Buy

Jun 11, 2026

Target

$275.00

Current

$269.95

Performance

23.14%

NTRA received a Outperform rating from Dan Leonard on Jun 11, 2026, aiming for 275. Momentum has favored the Buy call, with shares climbing from 269.95 to 269.95, rewarding those who trusted the recommendation.

GH

Buy

Jun 11, 2026

Target

$185.00

Current

$160.05

Performance

22.27%

On Jun 11, 2026, Dan Leonard published a Outperform outlook on GH, with a target of 185. Shares gained 22.27%, underscoring the accuracy of the bullish outlook toward 185.

A

Buy

May 28, 2026

Target

$155.00

Current

$134.29

Performance

-0.81%

Dan Leonard on May 28, 2026 assigned A a Outperform rating, with a price target of 155. The recommendation remains pending validation as shares consolidate around 134.29.

BIO

Buy

May 15, 2026

Target

$320.00

Current

$296.11

Performance

19.63%

On May 15, 2026, Dan Leonard reaffirmed BIO with a Outperform rating, targeting 320. The recommendation was supported by strong follow-through as the stock rose from 296.11 to 296.11.

AVTR

Hold

May 15, 2026

Target

$9.00

Current

$10.39

Performance

36.35%

AVTR was rated Sector Perform by Dan Leonard on May 15, 2026, with a price objective of 9. Despite caution, upside momentum rewarded risk-takers with gains to 10.39.

DHR

Buy

May 15, 2026

Target

$200.00

Current

$199.05

Performance

22.94%

On May 15, 2026, Dan Leonard initiated coverage on DHR with a Outperform rating and target of 200. The stock’s climb of 22.94% since the call highlights the foresight in the rating.

ILMN

Buy

May 15, 2026

Target

$170.00

Current

$190.20

Performance

33.44%

Dan Leonard issued a Outperform recommendation for ILMN on May 15, 2026, price target set at 170. Investors following the Buy call captured upside momentum, with shares now at 190.2.

RGEN

Buy

May 15, 2026

Target

$160.00

Current

$144.24

Performance

40.22%

On May 15, 2026, RGEN was evaluated by Dan Leonard, who gave a Outperform rating and target of 160. This case illustrates how a timely bullish rating can translate into tangible gains of 40.22%.

BRKR

Hold

May 07, 2026

Target

$45.00

Current

$60.06

Performance

37.34%

Dan Leonard rated BRKR as Neutral on May 07, 2026, setting a price target of 45. Despite the Hold call, shares climbed 37.34% to 60.06, revealing unexpected momentum.

CRL

Hold

Feb 25, 2026

Target

$175.00

Current

$233.41

Performance

39.30%

On Feb 25, 2026, CRL was given a Neutral rating by Dan Leonard, with a target price of 175. The stock rallied from 233.41 to 233.41 after the Hold rating, surprising to the upside.

TXG

Hold

Feb 20, 2026

Target

$20.00

Current

$42.73

Performance

126.32%

TXG received a Neutral rating from Dan Leonard on Feb 20, 2026, aiming for 20. Investors saw gains of 126.32% that the cautious stance didn’t fully capture.

IQV

Buy

Feb 06, 2026

Target

$240.00

Current

$207.85

Performance

10.86%

On Feb 06, 2026, Dan Leonard published a Buy outlook on IQV, with a target of 240. Shares gained 10.86%, underscoring the accuracy of the bullish outlook toward 240.

TMO

Hold

Oct 23, 2025

Target

$590.00

Current

$527.05

Performance

-7.84%

Dan Leonard on Oct 23, 2025 assigned TMO a Neutral rating, with a price target of 590. The call successfully avoided chasing as shares lost 7.84%.

CERT

Buy

Aug 07, 2025

Target

$15.00

Current

$6.77

Performance

-39.88%

On Aug 07, 2025, Dan Leonard reaffirmed CERT with a Buy rating, targeting 15. Shares slid 39.88% despite the recommendation, highlighting downside risks.

EXAS

Hold

Aug 07, 2025

Target

$53.00

Current

$104.91

Performance

143.07%

EXAS was rated Neutral by Dan Leonard on Aug 07, 2025, with a price objective of 53. Despite caution, upside momentum rewarded risk-takers with gains to 104.91.

MEDP

Sell

Jul 29, 2025

Target

$305.00

Current

$538.23

Performance

20.16%

On Jul 29, 2025, Dan Leonard initiated coverage on MEDP with a Sell rating and target of 305. The rating correctly identified downside risks, with the stock losing 20.16%.

Frequency Asked Questions

Who is Dan Leonard?

Dan Leonard is an analyst from RBC Capital specializing in the Healthcare sector.

What is Dan Leonard's success rate?

Dan Leonard currently has a success rate of +98.77%.

How many ratings has Dan Leonard issued?

Dan Leonard has issued 39 stock ratings so far.

What is the average return of Dan Leonard's calls?

Their stock ratings have generated an average return of +21.51%.

What is Dan Leonard's ranking?

Dan Leonard is ranked #715 out of 4718 analysts.

What types of ratings does Dan Leonard give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Dan Leonard?

You can follow Dan Leonard by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Dan Leonard?

Their latest rating was a Hold on TECH issued on 2026-07-09.